PLEASANTON, Calif., Jan. 10, 2012 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it has entered into a letter of intent regarding an expanded relationship with Massachusetts General Hospital, or MGH, for the purpose of developing products and/or therapies for the aesthetic dermatology and body shaping markets which leverage the parties' extensive knowledge base in the domain of cold technology.
